United States International Trade Commision Rulings And Harmonized Tariff Schedule
faqs.org  Rulings By Number  Rulings By Category  Tariff Numbers
faqs.org > Rulings and Tariffs Home > Rulings By Number > 2008 NY Rulings > NY N022574 - NY N022637 > NY N022633

Previous Ruling Next Ruling
NY N022633

February 6, 2008



TARIFF NO.: 3004.32.0000

Ms. Iliana G. Fuller
Allergan Inc.
2525 Dupont Drive
Irvine, CA 92612

RE: The tariff classification of Trivaris™ (triamcinolone acetonide injectable suspension, USP), from Ireland

Dear Ms. Fuller:

In your letter dated January 30, 2008, you requested a tariff classification ruling.

The subject product, Trivaris™ (triamcinolone acetonide injectable suspension, USP) is a synthetic glucocorticoid corticosteroid with anti-inflammatory action and is indicted for ophthalmic use, intramuscular use and intra-articular use. Trivaris™ is available in a single-use syringe consisting of 8 mg of the active ingredient, triamcinolone acetonide, contained in 0.1 ml. of aqueous gel suspension.

The applicable subheading for the Trivaris™ (triamcinolone acetonide injectable suspension, USP) will be 3004.32.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments ... consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses ... or in forms or packings for retail sale: Containing hormones or other products of heading 2937 but not containing antibiotics: Containing corticosteroid hormones, their derivatives or structural analogues.” The rate of duty will be free.

Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/.

This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at: www.fda.gov.

This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).

A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033.


Robert B. Swierupski

Previous Ruling Next Ruling

See also: